Page last updated: 2024-10-25

chlorzoxazone and Daytime Sleepiness

chlorzoxazone has been researched along with Daytime Sleepiness in 1 studies

Chlorzoxazone: A centrally acting central muscle relaxant with sedative properties. It is claimed to inhibit muscle spasm by exerting an effect primarily at the level of the spinal cord and subcortical areas of the brain. (From Martindale, The Extra Pharmacopoea, 30th ed, p1202)
chlorzoxazone : A member of the class of 1,3-benzoxazoles that is 1,3-benzoxazol-2-ol in which the hydrogen atom at position 5 is substituted by chlorine. A centrally acting muscle relaxant with sedative properties, it is used for the symptomatic treatment of painful muscle spasm.

Research Excerpts

ExcerptRelevanceReference
"Lasofoxifene was tested in 18 postmenopausal women with probe drugs for CYP2E1 and CYP2D6."2.72Effects of steady-state lasofoxifene on CYP2D6- and CYP2E1-mediated metabolism. ( Fisher, JM; Gardner, MJ; Kolluri, S; Moller, RA; Obach, RS; Taylor, AE; Walsky, RL, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moller, RA1
Fisher, JM1
Taylor, AE1
Kolluri, S1
Gardner, MJ1
Obach, RS1
Walsky, RL1

Trials

1 trial available for chlorzoxazone and Daytime Sleepiness

ArticleYear
Effects of steady-state lasofoxifene on CYP2D6- and CYP2E1-mediated metabolism.
    The Annals of pharmacotherapy, 2006, Volume: 40, Issue:1

    Topics: Administration, Oral; Chlorzoxazone; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cy

2006